Copyright Reports & Markets. All rights reserved.

Global Specialty Pharmaceutical Market Insights, Forecast to 2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Specialty Pharmaceutical Industry
  • 1.7 COVID-19 Impact: Specialty Pharmaceutical Market Trends

    • 2 Global Specialty Pharmaceutical Quarterly Market Size Analysis

    • 2.1 Specialty Pharmaceutical Business Impact Assessment - COVID-19
      • 2.1.1 Global Specialty Pharmaceutical Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Specialty Pharmaceutical Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Specialty Pharmaceutical Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Specialty Pharmaceutical Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Specialty Pharmaceutical Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Specialty Pharmaceutical Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Specialty Pharmaceutical Market
    • 3.5 Key Manufacturers Specialty Pharmaceutical Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Specialty Pharmaceutical Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Antibody
      • 1.4.2 Hormone
      • 1.4.3 Growth Factors
      • 1.4.4 Other
    • 4.2 By Type, Global Specialty Pharmaceutical Market Size, 2019-2021
      • 4.2.1 By Type, Global Specialty Pharmaceutical Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Specialty Pharmaceutical Price, 2020-2021

    5 Impact of Covid-19 on Specialty Pharmaceutical Segments, By Application

    • 5.1 Overview
      • 5.5.1 Tumor
      • 5.5.2 Diabetes
      • 5.5.3 Cardiovascular
      • 5.5.4 Hemophilia
      • 5.5.5 Other
    • 5.2 By Application, Global Specialty Pharmaceutical Market Size, 2019-2021
      • 5.2.1 By Application, Global Specialty Pharmaceutical Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Specialty Pharmaceutical Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Pfizer
      • 7.1.1 Pfizer Business Overview
      • 7.1.2 Pfizer Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.1.3 Pfizer Specialty Pharmaceutical Product Introduction
      • 7.1.4 Pfizer Response to COVID-19 and Related Developments
    • 7.2 Roche
      • 7.2.1 Roche Business Overview
      • 7.2.2 Roche Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.2.3 Roche Specialty Pharmaceutical Product Introduction
      • 7.2.4 Roche Response to COVID-19 and Related Developments
    • 7.3 Amgen
      • 7.3.1 Amgen Business Overview
      • 7.3.2 Amgen Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.3.3 Amgen Specialty Pharmaceutical Product Introduction
      • 7.3.4 Amgen Response to COVID-19 and Related Developments
    • 7.4 AbbVie
      • 7.4.1 AbbVie Business Overview
      • 7.4.2 AbbVie Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.4.3 AbbVie Specialty Pharmaceutical Product Introduction
      • 7.4.4 AbbVie Response to COVID-19 and Related Developments
    • 7.5 Novo Nordisk
      • 7.5.1 Novo Nordisk Business Overview
      • 7.5.2 Novo Nordisk Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.5.3 Novo Nordisk Specialty Pharmaceutical Product Introduction
      • 7.5.4 Novo Nordisk Response to COVID-19 and Related Developments
    • 7.6 Johnson & Johnson
      • 7.6.1 Johnson & Johnson Business Overview
      • 7.6.2 Johnson & Johnson Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.6.3 Johnson & Johnson Specialty Pharmaceutical Product Introduction
      • 7.6.4 Johnson & Johnson Response to COVID-19 and Related Developments
    • 7.7 Sanofi-Aventis
      • 7.7.1 Sanofi-Aventis Business Overview
      • 7.7.2 Sanofi-Aventis Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.7.3 Sanofi-Aventis Specialty Pharmaceutical Product Introduction
      • 7.7.4 Sanofi-Aventis Response to COVID-19 and Related Developments
    • 7.8 Merck
      • 7.8.1 Merck Business Overview
      • 7.8.2 Merck Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.8.3 Merck Specialty Pharmaceutical Product Introduction
      • 7.8.4 Merck Response to COVID-19 and Related Developments
    • 7.9 Eli Lilly
      • 7.9.1 Eli Lilly Business Overview
      • 7.9.2 Eli Lilly Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.9.3 Eli Lilly Specialty Pharmaceutical Product Introduction
      • 7.9.4 Eli Lilly Response to COVID-19 and Related Developments
    • 7.10 Novartis
      • 7.10.1 Novartis Business Overview
      • 7.10.2 Novartis Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.10.3 Novartis Specialty Pharmaceutical Product Introduction
      • 7.10.4 Novartis Response to COVID-19 and Related Developments
    • 7.11 3sbio
      • 7.11.1 3sbio Business Overview
      • 7.11.2 3sbio Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.11.3 3sbio Specialty Pharmaceutical Product Introduction
      • 7.11.4 3sbio Response to COVID-19 and Related Developments
    • 7.12 Changchun High Tech
      • 7.12.1 Changchun High Tech Business Overview
      • 7.12.2 Changchun High Tech Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.12.3 Changchun High Tech Specialty Pharmaceutical Product Introduction
      • 7.12.4 Changchun High Tech Response to COVID-19 and Related Developments
    • 7.13 CP Guojian Pharmacy
      • 7.13.1 CP Guojian Pharmacy Business Overview
      • 7.13.2 CP Guojian Pharmacy Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.13.3 CP Guojian Pharmacy Specialty Pharmaceutical Product Introduction
      • 7.13.4 CP Guojian Pharmacy Response to COVID-19 and Related Developments
    • 7.14 Biotech Pharma
      • 7.14.1 Biotech Pharma Business Overview
      • 7.14.2 Biotech Pharma Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.14.3 Biotech Pharma Specialty Pharmaceutical Product Introduction
      • 7.14.4 Biotech Pharma Response to COVID-19 and Related Developments
    • 7.15 Gelgen Biopharma
      • 7.15.1 Gelgen Biopharma Business Overview
      • 7.15.2 Gelgen Biopharma Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.15.3 Gelgen Biopharma Specialty Pharmaceutical Product Introduction
      • 7.15.4 Gelgen Biopharma Response to COVID-19 and Related Developments
    • 7.16 Innovent
      • 7.16.1 Innovent Business Overview
      • 7.16.2 Innovent Specialty Pharmaceutical Quarterly Production and Revenue, 2020
      • 7.16.3 Innovent Specialty Pharmaceutical Product Introduction
      • 7.16.4 Innovent Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Specialty Pharmaceutical Supply Chain Analysis
      • 8.1.1 Specialty Pharmaceutical Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Specialty Pharmaceutical Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Specialty Pharmaceutical Distribution Channels
      • 8.2.2 Covid-19 Impact on Specialty Pharmaceutical Distribution Channels
      • 8.2.3 Specialty Pharmaceutical Distributors
    • 8.3 Specialty Pharmaceutical Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Specialty Pharmaceutical, including the following market information:
      Global Specialty Pharmaceutical Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
      Global Specialty Pharmaceutical Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
      Global Specialty Pharmaceutical Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
      Global Specialty Pharmaceutical Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (MT)

      Key market players
      Major competitors identified in this market include Pfizer, Roche, Amgen, AbbVie, Novo Nordisk, Johnson & Johnson, Sanofi-Aventis, Merck, Eli Lilly, Novartis, 3sbio, Changchun High Tech, CP Guojian Pharmacy, Biotech Pharma, Gelgen Biopharma, Innovent, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Antibody
      Hormone
      Growth Factors
      Other

      Based on the Application:
      Tumor
      Diabetes
      Cardiovascular
      Hemophilia
      Other

      Buy now